Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy - Wikidata - awgldk - TriplyDB

Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy

Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy

http://www.wikidata.org/entity/Q24802767

about

Breast Cancer Research--the first ten years.

P2860

Q43238645-45CCE190-2809-4CCD-8686-832C23E002B4

P2860

Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy

http://www.wikidata.org/entity/Q24802767

description

2003 nî lūn-bûn

@nan

2003 թուականին հրատարակուած գիտական յօդուած

@hyw

2003 թվականին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

name

Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy

@ast

Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy

@en

Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy

@nl

type

label

Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy

@ast

Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy

@en

Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy

@nl

prefLabel

Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy

@ast

Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy

@en

Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy

@nl

P1433

Q24802767-CC0C981D-A924-430F-A8D6-10422AA7A8FF

P1476

Q24802767-C4FF8A86-FE04-4A81-9798-78C5D32BD40C

P2093

Q24802767-0100D604-A556-484A-BB66-8CDED901229D

Q24802767-FDA2799C-FEAE-46BD-9DD9-1CC707D4C073

P2860

Q24802767-08C3296F-B0AB-4B83-BB14-B6D9BCFF18A9

Q24802767-2A0D95AE-0A6F-4E5A-B774-EFAE94F88B43

Q24802767-49F6A24F-64A2-496C-9E72-61C47E38BB28

Q24802767-4CD5AE94-815C-4577-A6A3-1F2E0600AB2D

Q24802767-50DB0EBE-96EA-4C41-9B8B-54229E473BF7

Q24802767-55651A9F-1C25-4474-8BD8-B2C763DA139B

Q24802767-75091894-BFBB-4DAB-A9AA-D9A37C8629A6

Q24802767-9F47316C-542B-49CB-8F6A-F6967CE53D7E

Q24802767-B3C15659-F1E5-4587-AE8B-B13ABBFD6581

P2888

Q24802767-747D2495-5CCD-4369-9105-E632A6374797

P304

Q24802767-62EB5FE7-0AD9-43E6-BBCB-E42CAF0677AF

P31

Q24802767-F20F5DA6-2D8C-4F40-92EE-5F6E662FD941

P356

Q24802767-4A42B74C-C31F-4D59-B241-13428D2A9D7A

P407

Q24802767-1A4CBCDC-D8C5-4177-A618-6A43A94D5FF9

P433

Q24802767-90270656-5F35-4122-A303-A2E068E0479C

P478

Q24802767-59B8D7FF-2B1E-4315-A090-B23607BBEFC3

P577

Q24802767-3064283E-0E8E-4FCB-8D46-0C337526F923

P5875

Q24802767-730C859E-C42D-43AE-AD8D-8A4D5C9D59CC

P6179

Q24802767-4C648410-A644-41A7-AC28-60400540123F

P698

Q24802767-2B4EB175-4827-42A2-868F-44CDB83183D9

P932

Q24802767-E2F62A39-6934-4D85-AD0D-486E80AAB464

P356

P1433

Breast Cancer Research

P1476

Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy

@en

P2093

Bruce A J Ponder

http://www.w3.org/2001/XMLSchema#string

V Craig Jordan

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Aromatase inhibitors in the treatment and prevention of breast cancer.

The estrogen receptor: a model for molecular medicine.

Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy.

Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.

Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment.

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

P2888

P304

281-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR646

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9039364

http://www.w3.org/2001/XMLSchema#string

P6179

1005144114

http://www.w3.org/2001/XMLSchema#string

P698

14580241

http://www.w3.org/2001/XMLSchema#string

P932

314406

http://www.w3.org/2001/XMLSchema#string